Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 4, 2012, Pages 361-368

  Mertes, Paul M ^a   Demoly, Pascal ^b   Malinovsky, Jean M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Anaphylaxis; Anesthesia; Epinephrine; Neuromuscular blocking agent; Skin test; Tryptase

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CHLORHEXIDINE; DYE; ETHYLENE OXIDE; HYPNOTIC AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; LATEX; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHOLCODINE; ROCURONIUM; SUGAMMADEX; TRYPTASE; VASOPRESSIN;

ANAPHYLAXIS; ANESTHESIA; BLOOD; DRUG EFFICACY; ENZYME BLOOD LEVEL; HUMAN; HYPERSENSITIVITY REACTION; IN VITRO STUDY; INCIDENCE; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SENSITIZATION; SEX DIFFERENCE; SEX RATIO; SKIN TEST;

ADULT; ANALGESICS; ANESTHESIA; ANESTHETICS; CODEINE; DRUG HYPERSENSITIVITY; EPINEPHRINE; FEMALE; HUMANS; MALE; MORPHOLINES; NEUROMUSCULAR BLOCKING AGENTS; RISK FACTORS; SEX FACTORS; SKIN TESTS; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84864213946     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328355b82f     Document Type: Review

References (59)

1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-836.
2. Mertes PM, Tajima K, Regnier-Kimmoun MA, et al. Perioperative anaphylaxis. Med Clin North Am 2010; 94:761-789.
3. Nel L, Eren E. Peri-operative anaphylaxis. Br J Clin Pharmacol 2011; 71:647-658.
4. Mertes PM, Alla F, Trechot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128:366-373.
5. Moneret-Vautrin DA, Mertes PM. Anaphylaxis to general anesthetics. Chem Immunol Allergy 2010; 95:180-189.
6. Caimmi S, Caimmi D, Bernardini R, et al. Perioperative anaphylaxis: epidemiology. Int J Immunopathol Pharmacol 2011; 24:S21-S26.
7. Harper NJ, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64:199-211.
8. Gurrieri C, Weingarten TN, Martin DP, et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 2011; 113:1202-1212.
9. Beatty P, Kumar N, Ronald A. A complicated case of chlorhexidine- associated anaphylaxis. Anaesthesia 2011; 66:60-61.
10. Hunting AS, Nopp A, Johansson SG, et al. Anaphylaxis to Patent Blue V. I. Clinical aspects. Allergy 2010; 65:117-123.
11. Speca SJ, Boynes SG, Cuddy MA. Allergic reactions to local anesthetic formulations. Dent Clin North Am 2010; 54:655-664.
12. Fuzier R, Lapeyre-Mestre M, Mertes PM, et al. Immediate-and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing. Pharmacoepidemiol Drug Saf 2009; 18:595-601.
13. Harboe T, Guttormsen AB, Aarebrot S, et al. Suspected allergy to local anaesthetics: follow-up in 135 cases. Acta Anaesthesiol Scand 2010; 54:536-542.
14. Baldo BA, Fisher MM, Pham NH. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009; 39:325-344.
15. Florvaag E, Johansson SG. The pholcodine story. Immunol Allergy Clin North Am 2009; 29:419-427.
16. Florvaag E, Johansson SG, Irgens A, de Pater GH. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011; 66:955-960.
17. Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs): classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011; 66:818-829.
18. Canto MG, Andreu I, Fernandez J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9:293-297.
19. Viola M, Rumi G, Valluzzi RL, et al. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41:96-103.
20. Dona I, Blanca-Lopez N, Cornejo-Garcia JA, et al. Characteristics of subjects experiencing hypersensitivity to nonsteroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
21. Caimmi S, Benyahia B, Suau D, et al. Clinical value of negative skin tests to iodinated contrast media. Clin Exp Allergy 2010; 40:805-810.
22. Barthelmes L, Goyal A, Newcombe RG, et al. Adverse reactions to patent blue V dye: the NEW START and ALMANAC experience. Eur J Surg Oncol 2010; 36:399-403.
23. Mertes PM, Malinovsky JM, Mouton-Faivre C, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 2008; 122:348-352.
24. White V, Harvey JR, Griffith CD, et al. Sentinel lymph node biopsy in early breast cancer surgery: working with the risks of vital blue dye to reap the benefits. Eur J Surg Oncol 2011; 37:101-108.
25. Bezu C, Coutant C, Salengro A, et al. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 2011; 20:e55-e59.
26. Ramin S, Azar FP, Malihe H. Methylene blue as the safest blue dye for sentinel node mapping: emphasis on anaphylaxis reaction. Acta Oncol 2011; 50:729-731.
27. Nubret K, Delhoume M, Orsel I, et al. Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue. Transfusion 2011; 51:125-128.
28. Barthelmes L, Goyal A, Sudheer P, Mansel RE. Investigation of anaphylactic reaction after patent blue V dye injection. Breast 2010; 19:516-520.
29. Haque RA, Wagner A, Whisken JA, et al. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010; 65:396-400.
30. Bache S, Petersen JT, Garvey LH. Anaphylaxis to ethylene oxide: a rare and overlooked phenomenon? Acta Anaesthesiol Scand 2011; 55:1279-1282.
31. Opstrup MS, Mosbech H, Garvey LH. Allergic sensitization to ethylene oxide in patients with suspected allergic reactions during surgery and anesthesia. J Investig Allergol Clin Immunol 2010; 20:269-270.
32. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology 2011; 115:635-649.
33. Mertes PM, Bazin A, Alla F, et al. Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. J Investig Allergol Clin Immunol 2011; 21:171-178.
34. Jacobs JF, Baumert JL, Brons PP, et al. Anaphylaxis from passive transfer of peanut allergen in a blood product. N Engl J Med 2011; 364:1981-1982.
35. Atkins D, Malka-Rais J. Food allergy: transfused and transplanted. Curr Allergy Asthma Rep 2010; 10:250-257.
36. Matsuyama N, Hirayama F, Wakamoto S, et al. Application of the basophil activation test in the analysis of allergic transfusion reactions. Transfus Med 2009; 19:274-277.
37. Tobian AA, Savage WJ, Tisch DJ, et al. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51:1676-1683.
38. Azuma H, Hirayama J, Akino M, et al. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009; 49:214-218.
39. Marti-Carvajal AJ, Sola I, Gonzalez LE, et al. Pharmacological interventions for the prevention of allergic and febrile nonhaemolytic transfusion reactions. Cochrane Database Syst Rev 2010; CD007539.
40. Ewan PW, Dugue P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010; 40:15-31.
41. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21:442-453.
42. Garvey LH, Bech B, Mosbech H, et al. Effect of general anesthesia and orthopedic surgery on serum tryptase. Anesthesiology 2010; 112:1184-1189.
43. Mayer DE, Krauskopf A, Hemmer W, et al. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 2011; 212:96-101.
44. Sargur R, Cowley D, Murng S, et al. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. Clin Exp Immunol 2011; 163:339-345.
45. Rouzaire P, Proton G, Bienvenu F, et al. IgE antibody detection in the diagnosis of hypersensitivity to neuromuscular blocking agents. Acta Anaesthesiol Scand 2012; 56:263-264.
46. Laroche D, Chollet-Martin S, Leturgie P, et al. Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents. Anesthesiology 2011; 114:91-97.
47. Leysen J, Bridts CH, De Clerck LS, et al. Allergy to rocuronium: from clinical suspicion to correct diagnosis. Allergy 2011; 66:1014-1019.
48. Soetens F, Rose M, Fisher M. Timing of skin testing after a suspected anaphylactic reaction during anaesthesia. Acta Anaesthesiol Scand 2012.
49. Fisher M, Rose MA. Follow-up of patients after testing for anaesthetic allergy. Anaesth Intensive Care 2011; 39:1160.
50. Ramirez LF, Pereira A, Chiriac AM, et al. Negative predictive value of skin tests to neuromuscular blocking agents. Allergy 2012; 67:439-441.
51. Soar J, Perkins GD, Abbas G, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81:1400-1433.
52. Garvey LH, Belhage B, Kroigaard M, et al. Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark. Anesthesiology 2011; 115:111-116.
53. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107:620-624.
54. McDonnell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106:199-201.
55. Funnell AE, Griffiths J, Hodzovic I. A further case of rocuronium-induced anaphylaxis treated with sugammadex. Br J Anaesth 2011; 107:275-276.
56. Baldo BA, McDonnell NJ, PhamNH. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. Clin Exp Allergy 2011; 41:1663-1678.
57. Leysen J, Bridts CH, De Clerck LS, Ebo DG. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011; 66:526-527.
58. Clarke RC, Sadleir PH, Platt PR. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model*. Anaesthesia 2012; 67:266-273.
59. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66:217-219.